Enhancing the Australian National Health Survey Data for Use in a Microsimulation Model of Pharmaceutical Drug Usage and Cost

While static microsimulation models of the tax-transfer system are now available throughout the developed world, health microsimulation models are much rarer. This is, at least in part, due to the difficulties in creating adequate base micro-datasets upon which the microsimulation models can be constructed. In sharp contrast to tax-transfer modelling, no readily available microdata set typically contains all the health status, health service usage and socio-demographic information required for a sophisticated health microsimulation model. This paper describes three new techniques developed to overcome survey data limitations when constructing 'MediSim', a microsimulation model of the Australian Pharmaceutical Benefits Scheme. Comparable statistical matching and data imputation techniques may be of relevance to other modellers, as they attempt to overcome similar data deficiencies. The 2001 national health survey (NHS) was the main data source for MediSim. However, the NHS has a number of limitations for use in a microsimulation model. To compensate for this, we statistically matched the NHS with another national survey to create synthetic families and get a complete record for every individual within each family. Further, we used complementary datasets to impute short term health conditions and prescribed drug usage for both short- and long-term health conditions. The application of statistical matching methods and use of complementary data sets significantly improved the usefulness of the NHS as a base dataset for MediSim.

[1]  Ann Harding,et al.  The New Frontier of Health And Aged Care: Using Microsimulation to Assess Policy Options , 2004 .

[2]  A. Maynard,et al.  Dilemmas in regulation of the market for pharmaceuticals. , 2003, Health affairs.

[3]  H. Sutherland,et al.  Combining Household Income and Expenditure Data in Policy Simulations , 2002 .

[4]  Holly Sutherland,et al.  EUROMOD - the tax-benefit microsimulation model for the European Union , 2007 .

[5]  Fritz Scheuren,et al.  STATISTICAL MATCHING: PITFALLS OF CURRENT PROCEDURES , 2001 .

[6]  Anil Gupta,et al.  Modelling our future : population ageing health and aged care , 2007 .

[7]  Willard L. Rodgers,et al.  An Evaluation of Statistical Matching , 1984 .

[8]  Ann Harding,et al.  The Lifetime Distributional Impact of Government Health Outlays , 2002 .

[9]  A. Harding,et al.  Hospital admissions by socio‐economic status: does the Inverse care law‘ apply to older Australians? , 2006, Australian and New Zealand journal of public health.

[10]  Jonathan S. Turner,et al.  A new, linear programming approach to microdata file merging , 1978 .

[11]  Ann Harding,et al.  THE IMPACT OF DEMOGRAPHIC AND OTHER CHANGES ON EXPENDITURE ON PHARMACEUTICAL BENEFITS IN 2020 IN AUSTRALIA , 1998 .

[12]  Linc Thurecht,et al.  An Economic Forecasting Microsimulation Model of the Australian Pharmaceutical Benefits Scheme , 2003 .

[13]  Ann Harding,et al.  Distributional Impact of Government Outlays on the Australian Pharmaceutical Benefits Scheme in 2001-02 , 2004 .

[14]  M. D. Looper,et al.  Health inequalities in Australia: morbidity, health behaviours, risk factors and health service use , 2006 .

[15]  Holly Sutherland,et al.  Microsimulation Modelling for Policy Analysis: Challenges and Innovations , 2000 .

[16]  A. Harding,et al.  The ‘Inverse Care Law’, Population Ageing And The Hospital System: A Distributional Analysis , 2005 .

[17]  E. Docteur,et al.  Pharmaceutical Pricing and Reimbursement Policies in Sweden , 2007 .

[18]  Alan F. Karr,et al.  Statistical Matching: A Frequentist Theory, Practical Applications and Alternative Bayesian Approaches , 2007 .

[19]  Mark Woodward,et al.  Epidemiology: Study Design and Data Analysis , 1999 .

[20]  L. Brown,et al.  Moving Towards an Improved Microsimulation Model of the Australian Pharmaceutical Benefits Scheme , 2004 .

[21]  Ann Harding,et al.  Social Modelling and Public Policy: Application of Microsimulation Modelling in Australia , 2002, J. Artif. Soc. Soc. Simul..

[22]  Susanne Rässler,et al.  Statistical Matching: "A Frequentist Theory, Practical Applications, And Alternative Bayesian Approaches" , 2002 .

[23]  E. Docteur,et al.  Pharmaceutical Pricing and Reimbursement Policies in Canada , 2007 .

[24]  C. Mathers,et al.  Socioeconomic status and health in Australia , 2000, The Medical journal of Australia.

[25]  A Walker Distributional impact of higher patient contributions to Australia's Pharmaceutical Benefits Scheme. , 2000, Australian health review : a publication of the Australian Hospital Association.